Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: MASI

Masimo Corporation

Healthcare | Medical - Devices

No licensed closing price on file for MASI. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (FY2026)$-2.80

Masimo Corporation (NASDAQ: MASI) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 05:20 UTC.

What Masimo Corporation does

Masimo is a global medical technology company that develops and manufactures noninvasive patient monitoring technologies and hospital automation solutions. The company's healthcare business produces monitors, sensors, software, and cables that incorporate its core measurement technologies, including pulse oximetry and advanced parameters for brain function, hemodynamic, and regional oxygen monitoring.

Summarized from Masimo Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

MASI no longer appears among SEC's registered filers -- it may have been acquired, merged, or delisted. The figures on this page reflect the company's final filings and are no longer refreshed.
Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (FY2026)$-2.80
Debt/equity0.57

Revenue, margins & earnings

FY2021 Net income: $240MFY2021 Taxes & interest: $15MFY2021 Operating expenses: $487MFY2021 Cost of revenue: $401M$1.14BFY2021FY2022 Net income: $144MFY2022 Taxes & interest: $66MFY2022 Operating expenses: $849MFY2022 Cost of revenue: $180M$1.24BFY2022FY2023 Net income: $82MFY2023 Taxes & interest: $84MFY2023 Operating expenses: $600MFY2023 Cost of revenue: $510M$1.28BFY2023FY2024: net loss $305M on revenue $1.40B$1.40BFY2024FY2026: net loss $152M on revenue $1.53B$1.53BFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-06-12
Most recent filed transactions — June 2026:
  • 2026-06-12EVP, Chief Financial OfficerNon-Qualified Stock Option (Right to Buy)Returned to company-4,175$388.5K
  • 2026-06-12EVP, Chief Financial OfficerNon-Qualified Stock Option (Right to Buy)Returned to company-7,739$104.3K
  • 2026-06-12Chief Human Resources OfficerNon-Qualified Stock Option (Right to Buy)Returned to company-2,873$88.4K
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does Masimo Corporation do?

Masimo is a global medical technology company that develops and manufactures noninvasive patient monitoring technologies and hospital automation solutions.

When did MASI last file with the SEC?

Masimo Corporation's most recent SEC filing on record is a 10-Q filed 2026-05-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 05:20 UTC. This page is also available as JSON at /api/data?ticker=MASI and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for MASI and 5,000+ tickers.

Create a free account — keep MASI
For your agent
GET /api/data?ticker=MASI

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt